Comparison

Cresta vs Gong

Last updated:

Analyst verdict

Cresta wins contact-center conversations; Gong wins sales-org conversations. They're not really competitors — they're answers to different jobs in the same building. The wrong way to pick between them is by feature parity. The right way is by which side of the revenue funnel drives your forecast.

At a glance

Cresta · entry price
Custom — typical deployments $50K–$200K/yr
Gong · entry price
~$5,000/user/yr (estimated; pricing not publicly listed, contracts typically $50K-$300K+)
Cresta · raised
~$275M
Gong · raised
~$584M

Reference data

Dimension Cresta Gong
Pricing tier $$$ Enterprise
Entry price Custom — typical deployments $50K–$200K/yr ~$5,000/user/yr (estimated; pricing not publicly listed, contracts typically $50K-$300K+)
Funding stage Series D Series D+
Total raised ~$275M ~$584M
Valuation ~$1.0B ~$7.25B (peak, 2021; current estimated below $5B)
Target segment Mid-to-large contact center operations (200+ agents) Enterprise B2B sales organizations (30+ quota-carrying reps) where improving call quality, coaching at scale, and deal risk visibility across a large sales team justifies the platform investment
Founded 2017 2015

When to choose which

Choose Cresta if…

Choose Cresta if:

  • You run a contact center, not a sales org. 200+ agents handling support, claims, retention, or care calls — not AEs running discovery. The buyer is the VP of CX or COO of operations, not the CRO.
  • Real-time matters more than post-call. Cresta’s actual moat over Gong is in-call agent assist — Gong is post-call only. If your agents need a compliance prompt, an objection-handling cue, or a next-best-action during the conversation, Gong cannot do this job.
  • You’re in a regulated vertical. Healthcare, financial services, insurance — domains where compliance-aware drafting and audit trails are non-negotiable. Cresta’s vertical templates and custom-model training are the actual differentiator here, not the AI.
  • Your call volume is high enough to support custom-model training. Below ~50K calls/month the model investment doesn’t earn its keep; above that, Cresta’s domain-trained models materially out-perform foundation-model defaults.
  • You’re betting against full-replacement AI agents in your domain. Cresta is the augmentation play; if you believe Sierra/Decagon will replace agents wholesale in 2027, Cresta is the wrong bet. If you believe humans-in-the-loop survive in your vertical, it’s the right one.

Choose Gong if…

Choose Gong if:

  • You run a B2B sales org with 30+ AEs. Quota-carrying reps doing discovery, demo, and close calls. The buyer is the CRO or VP of Sales; the metric is win rate, ramp time, and forecast accuracy.
  • Call volume per rep is ≥3 substantive calls per week. This is the threshold where Gong’s coaching leverage compounds — a VP can review 1,000 calls/month via AI summaries instead of 10 calls directly. Below that volume, the ROI math collapses.
  • Forecasting is a first-class problem. Gong’s deal-risk signals, competitive-mention tracking, and pipeline visibility are the strongest in the category. Clari is closer than it was, but for sales-side intelligence Gong still sets the bar.
  • You can absorb the enterprise pricing. ~$5K/user/yr at typical enterprise contracts. For a 50-AE org that’s a $250K+ line item — defendable when win rate moves a point, hard to defend when call volume is thin.
  • You’re aware of the Microsoft Copilot risk. If your org runs deep on Microsoft 365 and Teams is the call surface, Copilot for Sales is the displacement threat to track. “Good enough” Copilot means Gong has to keep proving premium value in the analysis layer, not the recording layer.
  • You’re comfortable with the valuation overhang. $7.25B peak in 2021 against a current secondary market that doesn’t support it. The IPO delay is real; an acquisition (likely Salesforce or ServiceNow) is the more probable liquidity path. Buyers should plan for ownership change in the 24-month window.

Cresta and Gong both ship “conversation intelligence” — but they answer different jobs. This comparison is the GTMLens framing for when each is the right pick, when neither is, and what the 18-month risk on each looks like.

1. The strategic question, in one sentence

Which side of the revenue funnel actually drives your forecast — the customer-side conversations (support, retention, claims, care) or the buyer-side conversations (discovery, demo, close)?

If the customer side: Cresta. If the buyer side: Gong. The buildings overlap; the products do not. Most teams that try to make one tool do both end up with two underused tools.

2. Side-by-side

DimensionCrestaGong
Primary jobReal-time agent assist + post-call analysis for contact centersPost-call analysis + deal intelligence for B2B sales orgs
BuyerVP of CX, COO of operations, contact-center directorCRO, VP of Sales, RevOps
Conversation surfaceVoice (support calls), chat, email — high volume, often regulatedVideo (Zoom, Teams, Meet), voice — lower volume, higher stakes per call
In-call assistYes — real-time prompts, compliance cues, next-best-actionNo — post-call only
Last round$125M Series D, Apr 2025, ~$1.0B post$250M Series E, Jun 2021, $7.25B post (current secondary ~$5B)
Total raised~$275M~$584M
PricingCustom; typical $50K–$200K/yr~$5K/user/yr; typical $50K–$300K+ enterprise contracts
Vertical depthHealthcare, financial services, insurance — custom-model templatesHorizontal B2B sales; no vertical specialization
Competitive setGenesys/NICE/Five9 native AI; Sierra and Decagon (replacement)Clari, Chorus (ZoomInfo), Microsoft Copilot for Sales
Top 18-month riskSierra deploys in regulated verticals where Cresta’s moat is (2027 base case)Microsoft Copilot for Sales displaces “good enough” mid-market; valuation/IPO overhang

3. Where they overlap, where they don’t

The overlap is the conversation transcript and the AI analysis layer on top of it. Both can transcribe a call, summarize it, surface keywords, and flag risk patterns. If you stopped reading product marketing at “AI-powered conversation intelligence,” they look like the same product.

Three places they don’t overlap, and these are the buying signals:

  1. In-call vs post-call. Cresta’s real-time agent assist — a sidebar that suggests responses, flags compliance language, surfaces the right knowledge-base article during the call — is a different product from Gong’s post-call analysis. Gong’s post-call coaching is the strongest in the category; Cresta’s in-call assist is the strongest in its category. They are not interchangeable.
  2. Deal pipeline integration. Gong’s value compounds when paired with the CRM — deal risk signals, forecast accuracy, competitive intelligence, all feed pipeline-stage decisions. Cresta has no native CRM motion because there is no “deal” — there’s a ticket, a case, or a customer interaction. Different system of record.
  3. Custom-model training. Cresta’s contact-center customers train domain-specific models on their own conversation history; the depth is meaningful in regulated verticals where the cost of one wrong answer is material. Gong does not offer this — its models are horizontal across the customer base, which is the right shape for sales but the wrong shape for healthcare claims handling.

4. The buyer split is sharper than the product split

In practice, the cleanest way to pick is to ask: who’s signing the contract?

  • If it’s the CRO or VP of Sales, it’s Gong. Cresta has no story for this buyer.
  • If it’s the VP of CX or COO of operations, it’s Cresta. Gong has no story for this buyer.
  • If it’s the CFO looking to consolidate vendor spend, the answer is usually neither — it’s a Microsoft 365 + Salesforce native-AI play with whatever “good enough” coverage that buys you. Both Cresta and Gong lose this room.

The mistake we see most often is a CRO trying to extend Gong into customer-side conversations to consolidate vendors. The product fits poorly, the analytics are pointed at the wrong job, and the contact-center team ends up not using it. The reverse mistake — a VP CX trying to use Cresta for sales coaching — is rarer but equally bad.

5. The 18-month threats — different shapes, similar urgency

Cresta’s threat: replacement

Cresta sits at the augment-the-human position in a category where the capital is concentrated on replacement. Sierra at $15.8B post is signaling that the contact-center is getting a Bret-Taylor-led full-replacement AI agent, not a copilot for the human. Cresta’s defense is vertical depth + compliance + the customer’s own model — real defenses, but ones that have to hold for 24+ months while Sierra figures out healthcare and financial services.

If you’re buying Cresta in 2026, you’re explicitly betting that the human-agent doesn’t disappear in your vertical before your contract renewal. That bet is more defensible in healthcare and FS than in retail or telco — pick accordingly.

Gong’s threat: displacement by the platform

Gong’s threat is not Sierra-shaped — it’s Microsoft-shaped. Copilot for Sales, integrated natively into Teams and Outlook, is the “good enough” alternative that requires no new vendor relationship for organizations already on Microsoft 365. Gong’s defense is the depth of its analysis layer (deal risk, competitive mentions, forecast signals) — but each year Copilot closes the gap on the recording-and-transcription layer, the negotiation pressure compounds.

The valuation overhang is real and worth raising in procurement. $7.25B in 2021 secondary trades materially below that today; the IPO delay extends past four years; an acquisition (Salesforce, ServiceNow, or — contrarian — Microsoft itself) is more probable than a public listing. Buyers should plan for ownership change in the 24-month window and use that as negotiating leverage on contract length and price.

6. Verdict

Cresta wins contact-center conversations; Gong wins sales-org conversations. The choice is buyer-side, not feature-side. The wrong question is “which one is better?” The right question is “which side of the revenue funnel drives our forecast?”

If the answer is both, you need both — and that’s the honest read most procurement teams resist hearing. Trying to make one tool do both jobs is the failure mode we see most often, and it ends with a renewal review where neither tool gets defended.


Related: Cresta at $1B: the augment-the-human bet · Sierra vs Crescendo · AI SDR Market Map: Q2 2026

Author: Gagan Chawla. Last reviewed: May 2026.


Editorial independence: GTMLens accepts no vendor money, paid placements, or affiliate commissions. Our ratings and analysis are based solely on independent research. Read our editorial policy →